These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3914976)

  • 21. [Controlled clinical trial of a new antibiotic "CM 9164" (Midecacin) in dental and stomatological practice].
    Pappalardo G; Caltabiano M; Mattina R
    Minerva Stomatol; 1979; 28(3):167-86. PubMed ID: 399319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and antibacterial activity of some spiramycin derivatives.
    Adamski RJ; Heymann H; Geftic SG; Barkulis SS
    J Med Chem; 1966 Nov; 9(6):932-4. PubMed ID: 5339569
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man.
    Sifrim D; Janssens J; Vantrappen G
    Drugs Exp Clin Res; 1992; 18(8):337-42. PubMed ID: 1292916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man.
    Sifrim D; Matsuo H; Janssens J; Vantrappen G
    Drugs Exp Clin Res; 1994; 20(3):121-6. PubMed ID: 7956719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined action of semisynthetic penicillin and macrolide antibiotic on Pseudomonas aeruginosa in vitro and in vivo.
    Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1979 Oct; 49(5):331-6. PubMed ID: 119075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Photochemical affinity labeling of the macrolide binding site on the 70S E. coli ribosome].
    Siegrist S; Moreau N; Le Goffic F
    C R Acad Sci III; 1984; 299(3):49-51. PubMed ID: 6437621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fundamental and clinical studies on acetylspiramycin].
    Matsushita M; Yuasa M; Imamura M; Mihara S
    J Antibiot B; 1966 Aug; 19(4):305-8. PubMed ID: 4961328
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spiramycin derivatives. 2].
    Takahira H
    Jpn J Antibiot; 1970 Aug; 23(4):429-33. PubMed ID: 5312795
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of the growth of Escherichia coli and Saccharomyces cerevisiae with saliva containing miconazole in vitro].
    Pase U; Burtone G; Caruso C; De Toffoli A
    G Stomatol Ortognatodonzia; 1985; 4(2):47-8. PubMed ID: 3914975
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of long exposure to carcinogenics and other substances on the morphology and growth of Escherichia coli, Serratia plymuthicum and Saccharomyces cerevisiae.
    FUNDER S
    Acta Pathol Microbiol Scand; 1957; 40(1):25-38. PubMed ID: 13424272
    [No Abstract]   [Full Text] [Related]  

  • 32. [A study on midecamycin granules in acute respiratory diseases in infants (author's transl)].
    Sato H; Fujii S; Hirama Y; Nakazawa S; Watanabe O
    Jpn J Antibiot; 1977 Aug; 30(8):587-92. PubMed ID: 909147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-5. Toxicity of metabolites of miocamycin: acute toxicity of Mb2 in rats.
    Yokota M; Takeda U; Odaki M; Sasaki H; Kawaoto H; Watanabe H; Ishiwatari N; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1510-2. PubMed ID: 6334175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-4. Toxicity of metabolites of miocamycin: acute toxicity of Mb2 in mice.
    Yokota M; Takeda U; Odaki M; Sasaki H; Kawaoto H; Itoh T; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1507-9. PubMed ID: 6334174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of pH on spiramycin and on gram negative bacilli].
    Lorian V
    Presse Med (1893); 1969 May; 77(27):974. PubMed ID: 4893914
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-1. Toxicity of metabolites of miocamycin: acute toxicity of Mb1 in mice.
    Yokota M; Takeda U; Odaki M; Sasaki H; Kawaoto H; Itoh T; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1488-90. PubMed ID: 6334171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Midecamycin activity against aerobic and anaerobic bacteria].
    Dubini F; Balsari A
    G Ital Chemioter; 1985; 32(3):539-44. PubMed ID: 3836904
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of midecamycin against Staphylococcus aureus.
    Peng CF; Chen TS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-7. Toxicity of metabolites of miocamycin: acute toxicity of Mb6 in mice.
    Yokota M; Takeda U; Odaki M; Sasaki H; Kawaoto H; Itoh T; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1526-8. PubMed ID: 6334177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Basic and clinical studies on acetylspiramycin].
    Shioda K; Miki F; Higashi T; Iwasaki S; Akao M
    J Antibiot B; 1966 Aug; 19(4):292-6. PubMed ID: 5298188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.